Insurance Stocks Moving In Thursday’s Intraday Session
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.
Expert Ratings For Allstate
Within the last quarter, Allstate (NYSE:ALL) has observed the following analyst ratings:
Last 30 Days
1 Month Ago
2 Months Ago
UBS Maintains Neutral on Allstate, Raises Price Target to $139
UBS analyst Brian Meredith maintains Allstate (NYSE:ALL) with a Neutral and raises the price target from $118 to $139.
Wells Fargo Maintains Equal-Weight on Allstate, Raises Price Target to $135
Wells Fargo analyst Elyse Greenspan maintains Allstate (NYSE:ALL) with a Equal-Weight and raises the price target from $125 to $135.
Barclays Maintains Overweight on Allstate, Raises Price Target to $144
Barclays analyst Tracy Benguigui maintains Allstate (NYSE:ALL) with a Overweight and raises the price target from $141 to $144.
Insurance Stocks Moving In Monday’s Intraday Session
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.
Citigroup Maintains Neutral on Allstate, Lowers Price Target to $140
Citigroup maintains Allstate (NYSE:ALL) with a Neutral and lowers the price target from $142 to $140.
These New Digital Solutions Help Consumers Combat Skyrocketing Car Insurance Rates
Since 2011, car insurance rates have gone up by an average of 24% across the United States.
Piper Sandler Maintains Overweight on Allstate, Raises Price Target to $150
Piper Sandler analyst Paul Newsome maintains Allstate (NYSE:ALL) with a Overweight and raises the price target from $145 to $150.